Risedronate Sodium
24 NDCs across 7 manufacturers|21 Generic,3 Brand
Risedronate Sodium is used to treat postmenopausal osteoporosis and extramammary paget disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 27, 1998, and the first generic was approved Oct 5, 2007. FDA's Orange Book lists 25 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $27 million on Risedronate Sodium across 284,000 claims for 85,000 beneficiaries.
Risedronate Sodium is available as 24 NDCs from 7 manufacturers (21 generic, 3 brand), with NADAC prices from $1.52 to $353.50 per EA — the most expensive product costs about 233× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
24
21G / 3B
Manufacturers
7
competing in market
Price Spread
$1.52 – $353.50
per EA
7d Activity
avg -7.5% WoW · of 24 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sun Pharmaceutical Industries Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Bisphosphonate class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing RISEDRONATE SODIUM(1 pricing outlier)
Frequently Asked Questions
What is Risedronate Sodium used to treat?
Risedronate Sodium is used to treat postmenopausal osteoporosis and extramammary paget disease, per the National Library of Medicine's MED-RT classification.
When did Risedronate Sodium become available as a generic?
FDA approved the first generic Risedronate Sodium (ANDA) on Oct 5, 2007. The Orange Book currently lists 25 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Risedronate Sodium?
In 2024, Medicare Part D spent $27 million on Risedronate Sodium across 284,000 claims for 85,000 beneficiaries.
How many Risedronate Sodium products are on the market?
The Risedronate Sodium drug market contains 24 NDCs from 7 manufacturers — 21 generic and 3 brand products.
What is the price range for Risedronate Sodium?
NADAC reference prices for Risedronate Sodium range from $1.5151 to $353.4980 per EA — the most expensive product costs about 233× the cheapest.
Is generic Risedronate Sodium cheaper than brand?
The average generic NADAC for Risedronate Sodium is $8.9166 per EA, versus $166.3871 for brand-labeled products — brand versions average about 19× the generic price.
Which manufacturers make Risedronate Sodium?
7 manufacturers list Risedronate Sodium in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (5), Aurobindo Pharma Limited (4), Allergan, Inc. (3), Mylan Pharmaceuticals Inc. (3), Apotex Corp. (3).
How has the price of Risedronate Sodium changed recently?
Over the past 7 days, 12 Risedronate Sodium NDCs rose and 11 fell, with a market-wide average change of -7.5%.